LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 235,694 Value ($000) $127 Avg Close — Range —
Q4 2024
Shares 281,129 Value ($000) $180 Avg Close — Range —
Q3 2024
Shares 273,771 Value ($000) $378 Avg Close — Range —
Q2 2024
Shares 260,742 Value ($000) $378 Avg Close — Range —
Q1 2024
Shares 278,171 Value ($000) $620 Avg Close — Range —
Q4 2023
Shares 270,885 Value ($000) $526 Avg Close — Range —
Q3 2023
Shares 268,826 Value ($000) $395 Avg Close — Range —
Q2 2023
Shares 274,902 Value ($000) $874 Avg Close — Range —
Q1 2023
Shares 272,053 Value ($000) $1 Avg Close — Range —
Q4 2022
Shares 263,228 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 267,718 Value ($000) $1,962 Avg Close — Range —
Q2 2022
Shares 249,705 Value ($000) $1,628 Avg Close — Range —
Q1 2022
Shares 151,378 Value ($000) $764 Avg Close — Range —
Q4 2021
Shares 23,307 Value ($000) $180 Avg Close — Range —
Q3 2021
Shares 16,889 Value ($000) $250 Avg Close — Range —